News

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
I t’s hard to overstate just how revolutionary the development of medications like Ozempic and Wegovy has been for managing ...
One of the best catalysts for a stock's rise is the withdrawal of a rival. That was an important dynamic behind the double-digit-percentage rise of biotech Viking Therapeutics ' ( VKTX 0.32%) stock in ...
As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...
That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year ...
Hims & Hers Health Inc. posted better-than-expected first-quarter revenue as the company pivots away from making copycat ...
Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...
Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...